nach oben

Journal of Diabetes & Metabolic Disorders

Erschienen in:

05.04.2021 | Research article

Synergistic effect of micronutrients and metformin in alleviating diabetic nephropathy and cardiovascular Dysfunctioning in diabetic rat

verfasst von: Aaishwarya Deshmukh, Prajakta Manjalkar

Erschienen in: Journal of Diabetes & Metabolic Disorders | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Diabetic nephropathy (DN) and Cardiovascular Dysfunctioning (CVD) are interlinked with each other and one of the leading causes of irreversible renal damage and cardiovascular disease. Micronutrients play an effective role in type-2 diabetes (T2D) and its related complications. Our work aimed to elucidate the effect of micronutrients alone and in combination with standard anti-diabetic drug metformin on DN and CVD using streptozotocin induced diabetes in rats.

Methods

T2D was induced with a single intraperitoneal (i.p.) injection of freshly prepared streptozotocin (55 mg/kg), 15 min after intraperitoneal injection of nicotinamide (230 mg/kg). Commercially available kits were used to measure kidney parameters and cardiac marker level. Creatinine clearance was calculated by using formula and heart rate was recorded using powerlab software.

Results

Significant decrease in blood glucose levels were observed 14 days after initial administration in metformin treated, micronutrients treated and metformin with micronutrients treated groups compared with diabetic group. After 6 weeks of metformin and micronutrients treatment, serum creatinine, blood urea nitrogen (BUN) and lactate dehydrogenase (LDH) levels were significantly decreased as compared to diabetic group. Moreover, urine creatinine level, creatinine clearance and heart rate (HR) was increased significantly in metformin and micronutrients treated group compared with a diabetic group. Micronutrients therapy also normalised the general symptoms of diabetes.

Conclusion

The results obtained from this study indicate the synergistic effect of metformin and micronutrients against diabetic heart and kidney. Therefore, micronutrients may be used as an effective add-on therapy for DN and CVD.

Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93:137–88.CrossRef

Sharaf El Din UAA, Salem MM, Abdulazim DO. Diabetic nephropathy: Time to withhold development and progression -A review. J Adv Res. 2017;8:363–73. https://doi.org/10.1016/j.jare.2017.04.004.

Bugger H, Abel ED. Molecular mechanisms of diabetic cardiomyopathy. Diabetologia. 2014;57(4):660–71.CrossRef

Bernardi S, Michelli A, Zuolo G, Candido R, Fabris B. Update on RAAS modulation for the treatment of diabetic cardiovascular disease. J Diab Res. 2016;2016:1–17. https://doi.org/10.1155/2016/8917578.

Chandy A, Pawar B, John M, Isaac R. Association between diabetic nephropathy and other diabetic microvascular and macrovascular complications. Saudi J Kidney Dis Transplant. 2008;19(6):924–8.

Al-Harbi MS, Hamza RZ. Potential ameliorative effects of selenium and chromium supplementation against toxicity and oxidative stress in Streptozotocin diabetic rats. Int J Pharmacol. 2016;12(5):483–95.CrossRef

Vijay K, Suresh R, Loganathasamy K, Narayanan V, Pandiyan V, Satheesh Kumar T, et al. Anti-diabetic effects of vanadium Pentoxide Nanopartices in STZ induced diabetic rats. Int J Pure App Biosci. 2008;6(3):460–7.CrossRef

Uslu H, Uslu GA. Effects of chromium picolinate on oxidative stress and hyperglycemia in experimental type 2 diabetic rats. Asian J Pharm Clin Res. 2018;11(10):532–5.CrossRef

Morakinyo AO, Samuel TA, Adekunbi DA. Magnesium upregulates insulin receptor and glucose transporter-4 in streptozotocin-nicotinamide-induced type-2 diabetic rats. Endocr Regul. 2018;52:6–16. https://doi.org/10.2478/enr-2018-0002.CrossRefPubMed

10.

Sarkozy M, Fekete V, Szucs G, Torok S, Szucs C, Barkanyi J, et al. Anti-diabetic effect of a preparation of vitamins, minerals and trace elements in diabetic rats:a gender difference. BMC Endocr Disord. 2014;14(72):1–11.

11.

Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60:1577–85.CrossRef

12.

Mendez CE, Umpierrez GE. Pharmacotherapy for hyperglycemia in noncritically ill hospitalized patients. Diabetes Spectr. 2014;27(3):180–8.CrossRef

13.

Kohda Y, Shirakawa H, Yamane K, Otsuka K, Kono T, Terasaki F, et al. Prevention of incipient diabetic cardiomyopathy by high-dose thiamine. J Toxicol Sci. 2008;33(4):459–72.CrossRef

14.

Rabbani N, Alam SS, Riaz S, Larkin JR, Akhtar MW, Shafi T, et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia. 2009;52:208–12.CrossRef

15.

Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with type 2 diabetes mellitus and low vitamin D levels. Diabet Med. 2007;25:320–5.CrossRef

16.

Hurst PR, Stonehouse W, Jane CJ. Vitamin D supplementation reduces insulin resistance in south Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr. 2010;103:549–55.CrossRef

17.

Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects A randomized double-blind controlled trial. Diabetes Care. 2003;26(4):1147–52.CrossRef

18.

Guerrero-Romero F, Rodriguez-Moran M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, doubleblind, placebo-controlled clinical trial. J Hum Hypertens. 2009;23:245–51.CrossRef

19.

Lee NA, Reasner CA. Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM. Diabetes Care. 1994;17(12):1449–52.CrossRef

20.

Anderson RA, Cheng N, Bryden NA, Polansky MM, Cheng N, Chi J, et al. Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes. 1997;46:1786–91.CrossRef

21.

Ekpenyong CE. Micronutrient deficiency, a novel nutritional risk factor for insulin resistance and Syndrom X. Arch Food Nutr Sci. 2018;2:16–30.CrossRef

22.

Parvizi MR, Parviz M, Tavangar SM, Soltani N, Kadkhodaee M, Seifi B, et al. Protective effect of magnesium on renal function in STZ-induced diabetic rats. J Diab Metab Disord. 2014;13(84):1–9.

23.

Barooti A, Kamran M, Kharazmi F, Eftakhar E, Malekzadeh K, Talebi A, et al. Effect of oral magnesium sulfate administration on blood glucose hemostasis via inhibition of gluconeogenesis and FOXO1 gene expression in liver and muscle in diabetic rats. Biomed Pharmacother. 2019;109:1819–25. https://doi.org/10.1016/j.biopha.2018.10.164.CrossRefPubMed

24.

Selcuk MY, Aygen B, Dogukan A, Tuzcu Z, Akdemir F, Komorowski JR, et al. Chromium picolinate and chromium histidinate protects against renal dysfunction by modulation of NF-κB pathway in high-fat diet fed and Streptozotocin-induced diabetic rats. Nutr Metab. 2012;9(30):1–7.

25.

Reddi AS, Bollineni JS. Selenium-deficient diet induces renal oxidative stress and injury via TGF-b1 in normal and diabetic rats. Kidney Int. 2001;59:1342–53.CrossRef

26.

Kostov K. Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes: focusing on the processes of insulin secretion and signaling. Int J Mol Sci. 2019;20:1–15.CrossRef

27.

Kadkhodaee M, Mikaeili S, Zahmatkesh M, Golab F, Seifi B, Arab HA, et al. Alteration of renal functional, oxidative stress andinflammatory indices following hepatic ischemia-reperfusion. Gen PhysiolBiophys. 2012;31:195–202. https://doi.org/10.4149/gpb_2012_024.CrossRef

28.

Trujillo J, Chirino YI, Molina-Jijon E, Anderica-Romero AC, Tapia E, Pedraza-Chaverrí J. Renprotective effect of the antioxidant curcumin. Recent findings. Redox Biol. 2013;1(1):448–56. https://doi.org/10.1016/j.redox.2013.09.003.CrossRefPubMed

29.

Newman DJ, Price CP. Renal Function and Nitrogen Metabolism. In: Tietz Textbook of Clinical Chemistry. 3rd ed; 1999. p. 1204–64.

30.

Ganesha KR, Razdan R and Minaz N. Allantoin and micronutrients restores renal dysfunction in streptozotocin induced diabetic rats. J Diabetes Metab Manag. 2019;JDMM-10004.

31.

Zaulkffali AS, Md Razip NN, Syed Alwi SS, Abd Jalil A, Abd Mutalib MS, Gopalsamy B, et al. Vitamins D and E stimulate the PI3K-AKT Signalling pathway in insulin-resistant SK-N-SH neuronal cells. Nutrients. 2019;11:1–21.CrossRef

32.

Al-Quraishy S, Dkhil MA, Abdel AE, Moneim. Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. Int J Nanomedicine. 2015;10(1):6741–56. https://doi.org/10.2147/IJN.S91377.

33.

Singh S, Chandel HS, Kushwaha S, Malik J. Evaluation of Antidiabetic activity of combination of trace elements. Am Chem Sci J. 2015;6(1):25–37.CrossRef

34.

El Sayed DM, Amin SN, Yassa HD, Rashed LA, El Tablawy N, Elattar S. Effects of vitamin D and metformin on diabetic cardiomyopathy in rats with type 2 diabetes mellitus. IJAPB. 2017;4(4):1–13.CrossRef

35.

Alenzi FQ. Effect of Nicotinamide on experimental induced diabetes. Iran J Allergy Asthma Immunol. 2009;8(1):11–8.PubMed

36.

Suarez-Pinzon WL, Mabley JG, Power R. Szabo’C, Rabinovitch A. poly (ADPribose) polymerase inhibition prevents spontaneous and recurrent autoimmune diabetes in NOD mice by inducing apoptosis of islet-infiltrating leukocytes. Diabetes. 2003;52(7):1683–8.CrossRef

37.

Virág L. Structure and function of poly (ADP-ribose) polymerase- 1: role in oxidative stress-related pathologies. Curr Vasc Pharmacol. 2005;3(3):209–14.CrossRef

38.

Abdullah KM, Alam Md M, Iqbal Z, Naseem I. Therapeutic effect of vitamin B3 on hyperglycemia, oxidative stress and DNA damage in alloxan induced diabetic rat model. Biomed Pharmacother. 2018;105:1223–31. https://doi.org/10.1016/j.biopha.2018.06.085.CrossRefPubMed

39.

Hua Y, Clark S, Ren J, Sreejayan N. Molecular mechanisms of chromium in alleviating insulin resistance. J Nutr Biochem. 2012;23(4):313–9. https://doi.org/10.1016/j.jnutbio.2011.11.001.CrossRefPubMedPubMedCentral

40.

Zhou G, Myers R, Li Y, Chen Y, Shen X, Fenyk-Melody J, et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167–74.CrossRef

41.

Zhao P, Wang J, Ma H, Xiao Y, He L, Tong C, et al. A newly synthetic chromium complex—chromium (D-phenylalanine) 3 activates AMP-activated protein kinase and stimulates glucose transport. Biochem Pharmacol. 2009;77:1002–10.CrossRef

42.

Li Y, Ziegler R, Hamann A. Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes. Chin Med J. 2002;115(12):1843–8.

43.

Hei YJ, Farahbakhshian S, Chen X, Battell ML, McNeill JH. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Mol Cell Biochem. 1998;178:367–75.CrossRef

44.

Shang F, Zhang J, Zhao Li Z, Zhang J, Yin Y, Wang Y, et al. Cardiovascular protective effect of metformin and Telmisartan: reduction of PARP1 activity via the AMPK-PARP1 Cascade. PLoS One. 2016;11(3):1–16.CrossRef

45.

El-Aal AA, Abd El-Ghffar EA, Ghali AA, Zughbur MR, Sirdah MM. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial. Diabetes Metab Syndr. 2018;12(4):483–9. https://doi.org/10.1016/j.dsx.2018.03.013.CrossRefPubMed

Titel: Synergistic effect of micronutrients and metformin in alleviating diabetic nephropathy and cardiovascular Dysfunctioning in diabetic rat
verfasst von: Aaishwarya Deshmukh
Prajakta Manjalkar
Publikationsdatum: 05.04.2021
Verlag: Springer International Publishing
Erschienen in: Journal of Diabetes & Metabolic Disorders / Ausgabe 1/2021
Elektronische ISSN: 2251-6581
DOI: https://doi.org/10.1007/s40200-021-00776-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2021

Decomposition of socioeconomic inequality in growth disorders to its determinants in pediatric population: the CASPIAN IV study

Ramadan fasting and diabetes, latest evidence and technological advancements: 2021 update

The association between job stress and metabolic syndrome among medical university staff

Value-based eating habits; exploring religio-cultural nutritional behavior norms

Irrational beliefs trigger depression and anxiety symptoms, and associated with increased inflammation and oxidative stress markers in the 10-year diabetes mellitus risk: the ATTICA epidemiological study